Preclinical evidence that SSR128129E - A novel small-molecule multi-fibroblast growth factor receptor blocker - Radiosensitises human glioblastoma

European Journal of Cancer

Volumn 50, Issue 13, 2014, Pages 2351-2359

  Ader, Isabelle ^a   Delmas, Caroline ^a,b   Skuli, Nicolas ^a   Bonnet, Jacques ^b   Schaeffer, Paul ^c   Bono, Françoise ^c   Cohen Jonathan Moyal, Elizabeth ^a,b,d   Toulas, Christine ^a,b  

^a INSERM   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c SANOFI   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

FGFR inhibitor; Glioblastoma; Radioresistance; Radiosensitiser; SSR128129E

Indexed keywords

ANTHRANILIC ACID DERIVATIVE; FIBROBLAST GROWTH FACTOR RECEPTOR; INDOLIZINE DERIVATIVE; RADIOSENSITIZING AGENT; SSR128129E;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CELL HYPOXIA; DRUG EFFECTS; DRUG SCREENING; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN NEOPLASMS; CELL HYPOXIA; GLIOBLASTOMA; HUMANS; INDOLIZINES; MICE; ORTHO-AMINOBENZOATES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84905099678     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.05.012     Document Type: Article

References (18)

1. R. Stupp, M.E. Hegi, B. Neyns, R. Goldbrunner, U. Schlegel, and P.M. Clement et al. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma J Clin Oncol 28 2010 2712 2718
2. Z. Fuks, R.S. Persaud, A. Alfieri, M. McLoughlin, D. Ehleiter, and J.L. Schwartz et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo Cancer Res 54 1994 2582 2590
3. A. Haimovitz-Friedman, N. Balaban, M. McLoughlin, D. Ehleiter, J. Michaeli, and I. Vlodavsky et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis Cancer Res 54 1994 2591 2597
4. E. Cohen-Jonathan, C. Toulas, S. Monteil, B. Couderc, A. Maret, and J.J. Bard et al. Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells Cancer Res 57 1997 1364 1370
5. I. Ader, C. Toulas, F. Dalenc, C. Delmas, J. Bonnet, and E. Cohen-Jonathan et al. RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death Oncogene 21 2002 5998 6006
6. C. Delmas, C. Heliez, E. Cohen-Jonathan, D. End, J. Bonnet, and G. Favre et al. Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation Int J Cancer 100 2002 43 48
7. S. Monferran, N. Skuli, C. Delmas, G. Favre, J. Bonnet, and E. Cohen-Jonathan-Moyal et al. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB Int J Cancer 123 2008 357 364
8. N. Skuli, S. Monferran, C. Delmas, G. Favre, J. Bonnet, and C. Toulas et al. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma Cancer Res 69 2009 3308 3316
9. A. Ducassou, E. Uro-Coste, P. Verrelle, T. Filleron, A. Benouaich-Amiel, and V. Lubrano et al. Alphavbeta3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma Eur J Cancer 49 2013 2161 2169
10. C. Massabeau, I. Rouquette, V. Lauwers-Cances, J. Mazieres, J.M. Bachaud, and J.P. Armand et al. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 75 2009 696 702
11. V.P. Eswarakumar, I. Lax, and J. Schlessinger Cellular signalling by fibroblast growth factor receptors Cytokine Growth Factor Rev 16 2005 139 149
12. F. Bono, S.F. De, C. Herbert, B.K. De, M. Georgiadou, and P. Fons et al. Inhibition of tumour angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties Cancer Cell 23 2013 477 488
13. C. Herbert, U. Schieborr, K. Saxena, J. Juraszek, S.F. De, and C. Alcouffe et al. Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signalling Cancer Cell 23 2013 489 501
14. N. Skuli, S. Monferran, C. Delmas, I. Lajoie-Mazenc, G. Favre, and C. Toulas et al. Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells Cancer Res 66 2006 482 489
15. O. Lanvin, S. Monferran, C. Delmas, B. Couderc, C. Toulas, and E. Cohen-Jonathan-Moyal Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1alpha and survivin in U87 cells Eur J Cancer 49 2013 2884 2891
16. A. Persaud, P. Alberts, M. Hayes, S. Guettler, I. Clarke, and F. Sicheri et al. Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function EMBO J 30 2011 3259 3273
17. M. Calvani, A. Rapisarda, B. Uranchimeg, R.H. Shoemaker, and G. Melillo Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells Blood 107 2006 2705 2712
18. C. Conte, E. Riant, C. Toutain, F. Pujol, J.F. Arnal, and F. Lenfant et al. FGF2 translationally induced by hypoxia is involved in negative and positive feedback loops with HIF-1alpha PLoS One 3 2008 e3078